Vanguard Fiduciary Trust
INO icon

Vanguard Fiduciary Trust’s Inovio Pharmaceuticals INO Stock Holding History

Vanguard Fiduciary Trust’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$529K Buy
480,769
+88,703
+23% +$105K ﹤0.01% 3252
2026
Q1 		$682K Buy
+392,066
New +$645K ﹤0.01% 3097

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Fiduciary Trust's INO Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Inovio Pharmaceuticals (INO) stake by 23% in Q2 2026, buying an estimated $105K and bringing the position to 480,769 shares worth $529K. The position accounts for ﹤0.01% of the portfolio, ranked #3252.

Vanguard Fiduciary Trust first reported a position in INO in Q1 2026 and has held it in 2 quarters since. The position peaked at $682K in Q1 2026. 104 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Vanguard Fiduciary Trust held 480,769 shares of Inovio Pharmaceuticals worth $529K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 88,703 Inovio Pharmaceuticals shares in Q2 2026, an estimated $105K.
  • Inovio Pharmaceuticals made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3252 holding.
  • Vanguard Fiduciary Trust first reported a position in Inovio Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Inovio Pharmaceuticals position peaked at $682K in Q1 2026.
  • 104 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.